CDKN2A p.Ser7fs
c.18del · VCV4294202
Pathogenic
Single submitter
Classification
Pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
Conditions
1
melanoma-pancreatic cancer syndrome
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function in a haploinsufficient gene (ClinGen) |
|---|---|---|
| NMD | predicted | premature termination codon in exon 1 of 3 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP -0.34 | GERP -3.6 |
| Region caveats | ||
| Repeat context | tandem | GGCTCCATGCTGCTCCCCGCCGCC simple repeat · ambiguous alignment · confidence, not pathogenicity |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Variant & gene context
- Gene
- CDKN2A
- Protein
- p.Ser7fs
- Coding
- c.18del
- MANE Select
- NM_000077
- Type
- Deletion
- Location
- chr9:21974810 (GRCh38)
- Gene constraint
- LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 77.02 · 5 PDB
- Residue 7
- a modified residue (phosphoserine); the 'interaction with cdk5rap3 and mdm2' region
Disease context
melanoma-pancreatic cancer syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Familial atypical multiple mole melanoma syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
Similar variants
- CDKN2A p.Ser7= Benign ★ same residue
- CDKN2A p.Val7= Benign ★ same residue
- CDKN2A p.Ala36fs Pathogenic ★★ same condition
- CDKN2A p.Ala76fs Pathogenic/Likely pathogenic ★★ same condition
- CDKN2A p.Pro81fs Pathogenic ★★ same condition
- CDKN2A p.Ser43_Tyr44insTer Pathogenic ★★ same condition
- CDKN2A c.194-3646_194-3624del Uncertain significance ★★ same condition
- CDKN2A c.193+10del Likely benign ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-ser7fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown